Home › NDC Lookup › RxCUI directory › RxCUI 1492043

16.7 ML posaconazole 18 MG/ML Injection — RxCUI 1492043

RxNorm drug concept · Semantic clinical drug
RxCUI 1492043 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1492043
Official name16.7 ML posaconazole 18 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asposaconazole 300 MG per 16.7 ML Injection; posaconazole 300 MG in 16.7 ML Injection
FDA products mapped12
Package NDCs mapped12
Reported Medicaid activity (SDUD)55 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Posaconazole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats invasive aspergillosis, a serious mold infection. It also helps prevent serious Aspergillus and Candida infections when your immune system is severely weakened. The oral...
  • Delayed-release tablets can be taken with or without food. The oral suspension should be taken with a full meal. The injection is given by a clinician through a central line over a...
  • The most common are diarrhea, nausea, vomiting, fever, headache, cough and low potassium. Let your care team know if they are bothersome or severe.
  • Call right away for a racing or irregular heartbeat, fainting, signs of liver trouble, rising blood pressure or swelling, or severe vomiting and diarrhea. Those last two can keep t...
📖 Read our full Posaconazole guide →

🕸️ Concept Web — How 16.7 ML posaconazole 18 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 16.7 ML posaconazole 18 MG/ML Injection RxCUI 1492043

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Posaconazole 282446
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Noxafil 356772
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Posaconazole Injection 1724193
    • Posaconazole Injectable Product 1492041
    • Posaconazole Injection [Noxafil] 1724195
    • Noxafil Injectable Product 1492046
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Posaconazole 18 MG/ML SCDC · 1492040
  • Posaconazole Injection SCDF · 1724193
  • Posaconazole Injectable Product SCDG · 1492041

Brand-Name Concepts

📦 FDA Products & Package NDCs

12 products · 12 package NDCs
12 package NDCs map to RxCUI 1492043 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00085-1328-01 1 BOTTLE, GLASS in 1 CARTON (0085-1328-01) / 105 mL in 1 BO... NOXAFIL Merck Sharp & Dohme LLC 2006-09-15
00085-2224-02 8 PACKET in 1 CARTON (0085-2224-02) / 1 POWDER, FOR SUSPENS... NOXAFIL Merck Sharp & Dohme LLC 2021-06-08
00085-4324-02 60 TABLET, COATED in 1 BOTTLE (0085-4324-02) NOXAFIL Merck Sharp & Dohme LLC 2013-11-25
00085-4331-01 1 VIAL, GLASS in 1 CARTON (0085-4331-01) / 16.7 mL in 1 VIA... NOXAFIL Merck Sharp & Dohme LLC 2014-03-13
31722-0370-31 1 VIAL, GLASS in 1 CARTON (31722-370-31) / 16.7 mL in 1 VIA... POSACONAZOLE Camber Pharmaceuticals, Inc. 2024-12-23
42023-0195-01 1 VIAL, GLASS in 1 CARTON (42023-195-01) / 16.7 mL in 1 VIA... Posaconazole Par Health USA, LLC 2023-01-01
55150-0388-01 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-388-01) / 16.7 mL in... POSACONAZOLE Eugia US LLC 2023-12-26
63323-0685-17 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-685-17) / 16.7 mL in... Posaconazole Fresensius Kabi USA, LLC 2023-12-26
67457-0665-20 1 VIAL, GLASS in 1 CARTON (67457-665-20) / 16.7 mL in 1 VIA... posaconazole Mylan Institutional LLC 2024-03-22
68083-0577-01 1 VIAL in 1 CARTON (68083-577-01) / 16.7 mL in 1 VIAL posaconazole Gland Pharma Limited 2023-12-26
68462-0904-01 1 VIAL in 1 CARTON (68462-904-01) / 16.7 mL in 1 VIAL posaconazole GLENMARK PHARMACEUTICALS INC., USA 2023-12-27
68462-0911-01 1 VIAL in 1 CARTON (68462-911-01) / 16.7 mL in 1 VIAL posaconazole GLENMARK PHARMACEUTICALS INC., USA 2024-07-01
Observed labelers: Merck Sharp & Dohme LLC (4) · GLENMARK PHARMACEUTICALS INC., USA (2) · Camber Pharmaceuticals, Inc. (1) · Eugia US LLC (1) · Fresensius Kabi USA, LLC (1) · Gland Pharma Limited (1) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1837 Inj, posaconazole, 1 mg 6 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.